We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rules for Mylan's Oxybutynin Patent Challenge
Court Rules for Mylan's Oxybutynin Patent Challenge
September 19, 2006
Mylan Laboratories has cleared another legal hurdle in its quest to market a generic version of Johnson & Johnson’s incontinence drug Ditropan XL, with a court ruling favoring its challenge to the product’s patent.